Individualized Starting Dosage of Niraparib improves Safety with comparable Effectiveness

被引：0
作者：
不详
机构：
来源：
ONCOLOGY RESEARCH AND TREATMENT | 2023年 / 46卷 / 7-8期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：343 / 344
页数：2
相关论文
共 2 条
[1]   Prospective evaluation of the tolerability and efficacy of niraparib dosing based on baseline body weight and platelet count: Results from the PRIMA/ENGOT-OV26/GOG-3012 trial [J].
Mirza, Mansoor R. ;
Gonzalez-Martin, Antonio ;
Graybill, Whitney S. ;
O'Malley, David M. ;
Gaba, Lydia ;
Stephanie Yap, Oi Wah ;
Guerra, Eva M. ;
Rose, Peter G. ;
Baurain, Jean-Francois ;
Ghamande, Sharad A. ;
Denys, Hannelore ;
Prendergast, Emily ;
Pisano, Carmela ;
Follana, Philippe ;
Baumann, Klaus ;
Calvert, Paula M. ;
Korach, Jacob ;
Li, Yong ;
Malinowska, Izabela A. ;
Gupta, Divya ;
Monk, Bradley J. .
CANCER, 2023, 129 (12) :1846-1855
[2]  
Zhu J., 2023, SGO 2023
1